Source:http://linkedlifedata.com/resource/pubmed/id/20158332
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-2-17
|
pubmed:abstractText |
Baits containing recombinant raccoon poxvirus (RCN) expressing plague antigens (fraction 1 [F1] and a truncated form of the V protein-V307) were offered for voluntary consumption several times over the course of several months to a group of 16 black-tailed prairie dogs (Cynomys ludovicianus). For comparison, another group of prairie dogs (n = 12) was injected subcutaneously (SC) (prime and boost) with 40 microg of F1-V fusion protein absorbed to alum, a vaccine-adjuvant combination demonstrated to elicit immunity to plague in mice and other mammals. Control animals received baits containing RCN without the inserted antigen (n = 8) or injected diluent (n = 7), and as there was no difference in their survival rates by Kaplan-Meier analysis, all of them were combined into one group in the final analysis. Mean antibody titers to Yersinia pestis F1 and V antigen increased (p < 0.05) in the vaccinated groups compared to controls, but titers were significantly higher (p < 0.0001) in those receiving injections of F1-V fusion protein than in those orally vaccinated with RCN-based vaccine. Interestingly, upon challenge with approximately 70,000 cfu of virulent Y. pestis, oral vaccination resulted in survival rates that were significantly higher (p = 0.025) than the group vaccinated by injection with F1-V fusion protein and substantially higher (p < 0.0001) than the control group. These results demonstrate that oral vaccination of prairie dogs using RCN-based plague vaccines provides significant protection against challenge at dosages that simulate simultaneous delivery of the plague bacterium by numerous flea bites.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1557-7759
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20158332-Administration, Oral,
pubmed-meshheading:20158332-Animals,
pubmed-meshheading:20158332-Animals, Wild,
pubmed-meshheading:20158332-Antibodies, Bacterial,
pubmed-meshheading:20158332-Female,
pubmed-meshheading:20158332-Kaplan-Meier Estimate,
pubmed-meshheading:20158332-Male,
pubmed-meshheading:20158332-Plague,
pubmed-meshheading:20158332-Plague Vaccine,
pubmed-meshheading:20158332-Poxviridae,
pubmed-meshheading:20158332-Raccoons,
pubmed-meshheading:20158332-Rodent Diseases,
pubmed-meshheading:20158332-Sciuridae,
pubmed-meshheading:20158332-Vaccination,
pubmed-meshheading:20158332-Yersinia pestis
|
pubmed:articleTitle |
Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus).
|
pubmed:affiliation |
USGS National Wildlife Health Center, Madison, Wisconsin 53711, USA. trocke@usgs.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|